Heron Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed Its FY24 Revenue Guidance
Heron Therapeutics公布的第一季度财务业绩好于预期并重申其24财年收入指引后,该公司股价走高
Heron Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed Its FY24 Revenue Guidance
Heron Therapeutics公布的第一季度财务业绩好于预期并重申其24财年收入指引后,该公司股价走高
使用浏览器的分享功能,分享给你的好友吧